In a single experiment, scientists can decipher the entire genomes of many patient samples, animal models, or cultured cells.

RMAT designation is based on promising Phase 2 clinical data demonstrating NG01’s potential to reduce disability and ...

Labware for 3D cell culture, low-bind labware, and glycan analysis kits are designed to accelerate life science ...

Palisade Bio Inc. (NASDAQ:PALI) is one of the best growth stocks to buy right now. On February 23, Palisade Bio presented translational data from its Phase 1b study of PALI-2108. The findings ...

The collaboration between Leica Biosystems and Bio-Techne expands access to advanced RNA ISH technology for clinical ...

CAMBRIDGE, MA, March 10, 2026 (EZ Newswire) -- R3 Bio announced the release of its 2026 research report outlining early-stage progress in developing integrated, stem cell-derived biological platforms ...

Qlaris Bio appointed Fred Guerard, PharmD, as its president and CEO, according to a press release. The company is entering ...